Diane Jooris: July 11, 2017

Play

Bringing More Bright Ideas to Cancer Care

The Astellas Oncology C3 Prize® Returns for a Second Year to Inspire and Support Innovative Ideas

 

Diane Jooris

2016 Grand Prize Winner of the Astellas Oncology C3 Prize and co-founder of Oncomfort™, a health-tech company that uses virtual reality systems to potentially help patients manage the anxiety and pain of cancer care

 

Mark Reisenauer

Cancer caregiver and senior vice president, oncology, Astellas

 

By 2030, one study estimates that the global cancer burden is expected to grow to 20.3 million cancer cases.1 Despite significant advances in the treatment of cancer, patients and caregivers still face significant obstacles to receiving or providing optimal care. Cancer is a global challenge, but the effects of it are intensely personal.

Now in its second year, the C3 Prize (see-three prize) is designed to support bright ideas and potential solutions from anyone who has been affected by cancer. More specifically, the C3 Prize seeks submissions in areas where patients living with cancer and the cancer community face daily challenges such as: navigatingthe health care system, adhering to complex medical care requirements, coordinating care and surviving life post-treatment. Nearly anyone with a tangible idea to improve cancer care is welcome to apply; entrants do not need to have an established business or finished product. Full terms and conditions, including eligibility, can be found at C3prize.com.

Astellas Oncology is once again partnering with Robert Herjavec, investor on ABC’s Emmy Award-winning hit television show Shark Tank, and MATTER, a Chicago-based healthcare innovation community to help bring their ideas to life. Joining the group this year is the Union for International Cancer Control (UICC), who will host five finalists to pitch their ideas live at the World Cancer Leaders’ Summit on November 13th in Mexico City. From there, one grand prize winner will receive a $50,000 grant and a personal consultation with Herjavec. The four runners up will each receive $12,500. All will receive a one-year nights and weekends membership to MATTER.

On July 11th, Diane Jooris, 2016 C3 Prize Winner, and Mark Reisenauer, senior vice president, oncology business unit, Astellas, are available to discuss the C3Prize, raise awareness about the need to improve cancer care and explain how your listeners can get involved.

For more information please visit C3prize.com

 

 

More about Diane Jooris

Diane Jooris is the co-founder of Oncomfort™, a health-tech company that uses virtual reality systems to help patients by providing anxiety and pain self-management tools. She has a Master’s Degree in Clinical Psychology and International Relations as well as a Juris Doctor degree in Law. Diane was a Mind-Body Intervention Specialist at MD Anderson Cancer Center (Houston, Texas) and has over 20 years in corporate marketing and project management experience.

Diane is using the 2016 C3 Prize grant to help her develop a new virtual reality module and will be a judge for the 2017 C3 Prize.

More about Mark Reisenauer

Mark Reisenauer is senior vice president, oncology business unit of Astellas. In this role, he is responsible for commercial activities supporting marketed products, Astellas’ co-promotion partners and commercial planning for early stage oncology development compounds. Mark is a member of the Astellas US Management Committee.

Mark joined Astellas in 2011 as vice president, sales and marketing, oncology, where he led commercial activities supporting oncology products, Tarceva and the launch of Xtandi.

Prior to joining Astellas, Mark served as senior vice president and chief commercial officer of Micromet Inc. (now part of Amgen), where he led investor and public relations, new product planning and commercial launch planning. Previously, Mark held various sales and marketing leadership roles at Abbott, Pharmacia, Bristol-Myers Squibb and AstraZeneca.

Mark experienced firsthand the complexity of navigating cancer care while his father battled head and neck cancer. After losing his father, he has dedicated his energy toward cancer care innovation.

Mark earned a bachelor’s degree in political science from the University of Wisconsin.

Speak Your Mind

*